PetMeds (PETS) Q2 2027 earnings review
PetMeds cuts marketing costs, but sales fall and losses widen
PetMeds, the online pet pharmacy, saw its revenue drop deepen even as it hired a permanent chief executive and cut marketing bills. Net sales fell 19% from a year ago to $36 million, breaking below the roughly $41 million level of the prior two quarters. Chief executive Jeff Willard said the company cut its cost to win a new customer by 32%, yet the operating cash loss excluding one-offs widened to $3.6 million.
| Net sales | $35.8M -19.4% from a year ago |
|---|---|
| Operating cash loss, excluding one-offs | -$3.6M -$2.3M loss a year ago |
| Customer acquisition cost | -32% on 52% lower ad spend |
| Quarter-end cash | $11.4M down from $13.1M in Q1 |
⚖️ Verdict: 🔴 Bearish
The story got worse because top-line stabilization gave way to another step down, and the lower customer acquisition cost came from cutting the ad budget in half. By our math, those ad cuts mean PetMeds brought in about 30% fewer new buyers than a year ago, while administrative overhead excluding last year's investigation bills actually rose. One positive: drawing down warehouse inventory and stretching supplier payments kept the quarterly cash drain to $1.7 million.
The question now is whether the $37 million headquarters sale and new retail partners can rescue the balance sheet before working-capital relief runs out. Either the property deal closes on time and funds the turnaround, or ongoing operating losses and $19 million in unpaid sales taxes force distressed financing. The third-quarter property closing and the quarterly filing's liquidity note will settle it.
🐂 Bull Case
New Chief Executive Adds a Second Retail Partner
PetMeds ended its leadership gap by naming Jeff Willard as permanent Chief Executive Officer and President, replacing interim leader Leslie Campbell. A day before the results, the online pet pharmacy also announced a partnership with Pet Supermarket "to Expand Pharmacy Offering Across Retail and Digital Channels". That deal follows July's pharmacy launch across more than 150 Rural King stores, adding a second retail chain to its partner business.
What to watch: partner revenue and contract terms in the quarterly filing. If retail partners bring in orders without requiring PetMeds to pay for the advertising, they can slow the slide in total sales.
Working Capital Shifts Slowed the Cash Drain
The Florida company ended September with $11.4 million in cash, down $1.7 million from June after dropping $8.3 million in the first quarter. By our math, subtracting first-quarter cash flows from the six-month totals leaves a second-quarter free cash flow loss of $1.6 million, down from $8.3 million in the first quarter.
PetMeds slowed the cash drain by selling down warehouse stock and taking longer to pay suppliers. Inventories fell by $2.2 million during the quarter, while unpaid supplier bills rose by $3.0 million to $15.3 million. Because a company can only empty its shelves once, this cash relief is temporary while operating losses grow.
What to watch: closing of the $37 million headquarters sale and leaseback, due in the third quarter. Closing that deal would replenish the bank account before supplier bills come due.
🐻 Bear Case
Sales Broke Below the Two-Quarter Floor
"We have stabilized the operations of the business and our focus now is on transforming our core direct-to-consumer pharmacy business and making PetMeds a leaner, more profitable company at the size we are today," chief executive Jeff Willard said. Yet revenue did not stay at that size.
Second-quarter net sales fell 19.4% from a year ago to $35.8 million, driven by a "decline in prescription medication sales and higher consumer promotional usage". After holding between $41.0 million and $42.8 million in the previous two quarters, revenue dropped 12.8% from the first quarter.
Discounts hurt profitability as well as revenue. Gross margin slipped 0.6 percentage points from a year ago to 27.4% because of an "unfavorable product mix shift and lower manufacturer rebates as a percentage of sales, partially offset by lower net freight costs per order".
What to watch: reorder sales and AutoShip recurring revenue share in the quarterly filing. Another drop in repeat orders would show that existing pet owners are leaving faster than discounts can keep them.
Lower Acquisition Cost Came From Halving Ads
Management pointed to marketing savings as proof that its turnaround is working. Willard noted that "this quarter we cut our cost to acquire a new customer by 32% from a year ago".
PetMeds calculates customer acquisition cost by dividing total advertising expense by the number of new customers acquired. In the second quarter, the retailer cut advertising spending by 52.3% from a year ago, to $2.1 million from $4.3 million. When ad spending falls by more than half and the cost per customer falls by a third, simple arithmetic shows that the number of new buyers fell by about 30% from a year ago, by our math.
Cutting the least effective ads always lowers the average cost per buyer, but it leaves the pharmacy with a smaller pool of new pet owners to refill prescriptions in future quarters.
What to watch: the exact new-customer count in the quarterly filing, compared with 70,000 in the first quarter. A reading near 50,000 would confirm that marketing cuts are shrinking the customer base.
Underlying Overhead Rose Once Legal Bills Lapsed
PetMeds reported that its net loss narrowed to $6.4 million from $8.5 million a year ago because of lower general and administrative overhead and lower advertising. That comparison benefits from $2.1 million of audit investigation fees and $1.2 million of severance in last year's second quarter.
- General and administrative expense: $12.0 million, down 15.6% as reported, but up 9.8% from a year ago excluding severance and investigation fees by our math
- General and administrative share of revenue: 33.5%, up 1.5 percentage points from a year ago
- Adjusted EBITDA (operating cash profit excluding one-offs): a loss of $3.6 million, 57.3% worse than the $2.3 million loss a year ago
What to watch: third-quarter general and administrative spending in dollars. Until overhead falls faster than sales without relying on lapsed legal bills, operating losses will keep growing.
Risks this quarter didn't answer
Five standing concerns from the first quarter received no update in the second-quarter press release and await the quarterly filing or earnings call.
- Property sale and leaseback: no update on the $37 million Delray Beach building sale signed in July, which management expected to close within about 120 days.
- Buyout proposal: no mention of the non-binding $3.00 per share SilverCape offer or the shareholder rights plan expiring December 2, 2026.
- New customers acquired: omitted from the release after printing at 70,000 in the first quarter; usually disclosed in the filing's management discussion.
- Recurring sales mix: AutoShip and membership share of gross sales was not in the release after reaching 61.5% in the first quarter.
- Pricing lawsuits: no update on the two consumer class-action suits over reference pricing.
💲 Other KPIs
Unremitted past sales tax liabilities fell by $1.7 million from June and by $3.3 million since March 2026. PetMeds paid down those state obligations in cash, which still exceed the company's $11.4 million cash balance and leave working capital at negative $17.0 million.
Warehouse stock dropped 25.6% from the first quarter and is down more than half from $13.6 million in March 2026. Liquidating stock generated $7.3 million of operating cash over the first six months of the fiscal year.
Weighted-average shares rose 0.9% from a year ago and declined slightly from 21.7 million in the first quarter. Issued common shares on the balance sheet rose to 22.1 million from 21.4 million in March on stock compensation.
❓ Key Questions
Has the $37 million headquarters sale closed?
The July agreement had an expected 120-day closing window ending in November. With $11.4 million of cash and $18.9 million of sales tax payable, the closing date and annual rent cost determine PetMeds' cash runway.
How many new customers did PetMeds acquire in Q2?
Management reported a 32% drop in acquisition cost while cutting ad spend by 52%. Disclosing the exact buyer count in the quarterly filing will show whether new customer volume fell near 50,000.
Why did overhead rise after stripping out legal fees?
Excluding last year's investigation and severance charges, general and administrative expenses grew nearly 10% from a year ago to $11.9 million despite a 19% drop in revenue.
What is the status of the $3.00 SilverCape buyout offer?
PetMeds appointed a permanent chief executive without mentioning the non-binding acquisition proposal under review in the first quarter or whether the board will let its poison pill expire on December 2.
How much revenue do Rural King and Pet Supermarket bring?
The company now has two retail pharmacy partnerships, but total net sales dropped 13% from last quarter. Investors need to know when partner orders will show up in revenue.